KATHLEEN POWERS: Open Payments
NPI 1689386112 · KINGSPORT, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$717 in 50 payments from 14 companies in 2025. Trend: 2023 $115 · 2024 $443 · 2025 $717
Food & beverage: $717
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $149 |
| ABBVIE INC. | 17 | $136 |
| GlaxoSmithKline, LLC. | 6 | $108 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $51 |
| Otsuka America Pharmaceutical, Inc. | 2 | $40 |
| Lilly USA, LLC | 2 | $40 |
| Daiichi Sankyo Inc. | 1 | $28 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $28 |
| Vanda Pharmaceuticals Inc. | 1 | $26 |
| Xeris Pharmaceuticals, Inc. | 1 | $24 |
Products named: VRAYLAR, Ozempic, SHINGRIX, Kerendia, REXULTI, MOUNJARO, TRELEGY ELLIPTA, INJECTAFER.
Industry payments across TN — which companies pay providers there.
